Type |
Details |
Score |
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
559
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Chen Y |
Year: |
2021 |
Journal: |
Cell Prolif |
Title: |
Nbs1-mediated DNA damage repair pathway regulates haematopoietic stem cell development and embryonic haematopoiesis. |
Volume: |
54 |
Issue: |
3 |
Pages: |
e12972 |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion A, Zhizhuang Joe Zhao |
Allele Type: |
Transgenic |
Attribute String: |
Humanized sequence, Inserted expressed sequence |
|
•
•
•
•
•
|
Publication |
First Author: |
Hsu YC |
Year: |
2019 |
Journal: |
Blood Adv |
Title: |
Phf6-null hematopoietic stem cells have enhanced self-renewal capacity and oncogenic potentials. |
Volume: |
3 |
Issue: |
15 |
Pages: |
2355-2367 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kardosova M |
Year: |
2018 |
Journal: |
Haematologica |
Title: |
C/EBPγ is dispensable for steady-state and emergency granulopoiesis. |
Volume: |
103 |
Issue: |
8 |
Pages: |
e331-e335 |
|
•
•
•
•
•
|
Publication |
First Author: |
de Araujo ED |
Year: |
2019 |
Journal: |
Nat Commun |
Title: |
Structural and functional consequences of the STAT5BN642H driver mutation. |
Volume: |
10 |
Issue: |
1 |
Pages: |
2517 |
|
•
•
•
•
•
|
Allele |
Name: |
vav 1 oncogene; mutation 1, Bruce Beutler |
Allele Type: |
Chemically induced (ENU) |
Attribute String: |
Not Specified |
|
•
•
•
•
•
|
Strain |
Attribute String: |
chemically induced mutation, coisogenic, mutant strain |
|
•
•
•
•
•
|
Allele |
Name: |
vav 1 oncogene; mutation 2, Bruce Beutler |
Allele Type: |
Chemically induced (ENU) |
Attribute String: |
Not Specified |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant strain, chemically induced mutation, coisogenic |
|
•
•
•
•
•
|
Allele |
Name: |
vav 1 oncogene; mutation 3, Bruce Beutler |
Allele Type: |
Chemically induced (ENU) |
Attribute String: |
Not Specified |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant strain, chemically induced mutation, coisogenic |
|
•
•
•
•
•
|
Allele |
Name: |
vav 1 oncogene; mutation 4, Bruce Beutler |
Allele Type: |
Chemically induced (ENU) |
Attribute String: |
Not Specified |
|
•
•
•
•
•
|
Strain |
Attribute String: |
chemically induced mutation, mutant strain, coisogenic |
|
•
•
•
•
•
|
Allele |
Name: |
vav 1 oncogene; mutation 5, Bruce Beutler |
Allele Type: |
Chemically induced (ENU) |
Attribute String: |
Not Specified |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant strain, coisogenic, chemically induced mutation |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion, E Camilla Forsberg |
Allele Type: |
Transgenic |
Attribute String: |
Reporter |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion A, Alison Moliterno |
Allele Type: |
Transgenic |
Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion E, Alison Moliterno |
Allele Type: |
Transgenic |
Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion 1, E Camilla Forsberg |
Allele Type: |
Transgenic |
Attribute String: |
Reporter |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Phf6/Phf6 Tg(Vav1-cre)#Cgp/? |
Background: |
Not Specified |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Phf6/? Tg(Vav1-cre)#Cgp/? |
Background: |
Not Specified |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Vav1/Vav1 |
Background: |
C57BL/6J-Vav1 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Vav1/Vav1 |
Background: |
C57BL/6J-Vav1 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Vav1/Vav1 |
Background: |
C57BL/6J-Vav1 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Vav1/Vav1 |
Background: |
C57BL/6J-Vav1 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Vav1/Vav1 |
Background: |
C57BL/6J-Vav1 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Rasa3/Rasa3 Tg(Vav1-cre)1Cgp/? |
Background: |
involves: 129S1/SvImJ * C57BL/6J |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Mirc27/Mirc27 Tg(Vav1-cre)#Cgp/? |
Background: |
involves: 129S4/SvJae * C57BL/6 * C57BL/6NRj |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Mirc30/Mirc30 Tg(Vav1-cre)#Cgp/? |
Background: |
involves: 129S4/SvJae * C57BL/6 * C57BL/6NRj |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
524
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
509
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Ainsua-Enrich E |
Year: |
2015 |
Journal: |
J Immunol |
Title: |
The adaptor 3BP2 is required for KIT receptor expression and human mast cell survival. |
Volume: |
194 |
Issue: |
9 |
Pages: |
4309-18 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hatani T |
Year: |
2008 |
Journal: |
Curr Med Chem |
Title: |
Adaptor protein 3BP2 and cherubism. |
Volume: |
15 |
Issue: |
6 |
Pages: |
549-54 |
|
•
•
•
•
•
|
Publication |
First Author: |
Levaot N |
Year: |
2011 |
Journal: |
Cell |
Title: |
Loss of Tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism. |
Volume: |
147 |
Issue: |
6 |
Pages: |
1324-39 |
|
•
•
•
•
•
|
Publication |
First Author: |
Qu X |
Year: |
2005 |
Journal: |
Biochemistry |
Title: |
Tyrosine phosphorylation of adaptor protein 3BP2 induces T cell receptor-mediated activation of transcription factor. |
Volume: |
44 |
Issue: |
10 |
Pages: |
3891-8 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
This entry represents the SH2 domain of VAV1 from vertebrates.VAV1 (also known as proto-oncogene vav) is expressed predominantly in the hematopoietic system and it plays an important role in the development and activation of B and T cells [, , ]. It is activated by tyrosine phosphorylation to function as a guanine nucleotide exchange factor (GEF) for Rho GTPases following cell surface receptor activation, triggering various effects such as cytoskeletal reorganization, transcription regulation, cell cycle progression, and calcium mobilization [, ]. It also serves as a scaffold protein and has been shown to interact with Ku70, Socs1, Janus kinase 2, SIAH2, S100B, Abl gene, ZAP-70, SLP76, and Syk, among others []. The VAV protein family members are multiple domain proteins, including Vav from flies and VAV1/2/3 from mammals. VAV1 predominates in hematopoietic cells, whereas VAV2 and VAV3 are more broadly expressed. They have a calponin homology (CH) domain, an acidic domain (AC), a Dbl homology (DH) domain, a pleckstrin homology (PH) domain, a cysteine-rich (CR) domain containing a zinc finger, and a complex region with SH2 and SH3 domains. Therefore they may participate in the activity of several pathways [, ]. They are signal transducer proteins that couple tyrosine kinase signals with the activation of the Rho/Rac GTPases, [, , ]. |
|
•
•
•
•
•
|
Publication |
First Author: |
Daria D |
Year: |
2008 |
Journal: |
Blood |
Title: |
The retinoblastoma tumor suppressor is a critical intrinsic regulator for hematopoietic stem and progenitor cells under stress. |
Volume: |
111 |
Issue: |
4 |
Pages: |
1894-902 |
|
•
•
•
•
•
|
Publication |
First Author: |
Dzhagalov I |
Year: |
2007 |
Journal: |
J Immunol |
Title: |
Regulation of CD8+ T lymphocyte effector function and macrophage inflammatory cytokine production by retinoic acid receptor gamma. |
Volume: |
178 |
Issue: |
4 |
Pages: |
2113-21 |
|
•
•
•
•
•
|
Publication |
First Author: |
Soma S |
Year: |
2024 |
Journal: |
Stem Cells |
Title: |
O-Linked N-Acetylglucosamine Transferase Ensures Survival of Mouse Fetal Liver Hematopoietic Progenitors Partly by Regulating Bcl-xL and Oxidative Phosphorylation. |
Volume: |
42 |
Issue: |
1 |
Pages: |
55-63 |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, mutant strain, targeted mutation, transgenic |
|
•
•
•
•
•
|
Publication |
First Author: |
Leonards K |
Year: |
2020 |
Journal: |
Nat Commun |
Title: |
Nuclear interacting SET domain protein 1 inactivation impairs GATA1-regulated erythroid differentiation and causes erythroleukemia. |
Volume: |
11 |
Issue: |
1 |
Pages: |
2807 |
|
•
•
•
•
•
|
Publication |
First Author: |
Taniguchi Ishikawa E |
Year: |
2012 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Connexin-43 prevents hematopoietic stem cell senescence through transfer of reactive oxygen species to bone marrow stromal cells. |
Volume: |
109 |
Issue: |
23 |
Pages: |
9071-6 |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion 1, Thomas Graf |
Allele Type: |
Transgenic |
Attribute String: |
Recombinase |
|
•
•
•
•
•
|
Publication |
First Author: |
Thoms JA |
Year: |
2011 |
Journal: |
Blood |
Title: |
ERG promotes T-acute lymphoblastic leukemia and is transcriptionally regulated in leukemic cells by a stem cell enhancer. |
Volume: |
117 |
Issue: |
26 |
Pages: |
7079-89 |
|
•
•
•
•
•
|
Publication |
First Author: |
Xing S |
Year: |
2008 |
Journal: |
Blood |
Title: |
Transgenic expression of JAK2V617F causes myeloproliferative disorders in mice. |
Volume: |
111 |
Issue: |
10 |
Pages: |
5109-17 |
|
•
•
•
•
•
|
Publication |
First Author: |
Majumder A |
Year: |
2012 |
Journal: |
Exp Hematol |
Title: |
A46, a benzothiophene-derived compound, suppresses Jak2-mediated pathologic cell growth. |
Volume: |
40 |
Issue: |
1 |
Pages: |
22-34 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sano S |
Year: |
2019 |
Journal: |
JACC Basic Transl Sci |
Title: |
JAK2 V617F -Mediated Clonal Hematopoiesis Accelerates Pathological Remodeling in Murine Heart Failure. |
Volume: |
4 |
Issue: |
6 |
Pages: |
684-697 |
|
•
•
•
•
•
|
Publication |
First Author: |
Matsuura S |
Year: |
2020 |
Journal: |
Blood |
Title: |
Adhesion to fibronectin via α5β1 integrin supports expansion of the megakaryocyte lineage in primary myelofibrosis. |
Volume: |
135 |
Issue: |
25 |
Pages: |
2286-2291 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kirabo A |
Year: |
2012 |
Journal: |
Am J Pathol |
Title: |
The small molecule inhibitor G6 significantly reduces bone marrow fibrosis and the mutant burden in a mouse model of Jak2-mediated myelofibrosis. |
Volume: |
181 |
Issue: |
3 |
Pages: |
858-65 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jin X |
Year: |
2013 |
Journal: |
PLoS One |
Title: |
Generation of a new congenic mouse strain with enhanced chymase expression in mast cells. |
Volume: |
8 |
Issue: |
12 |
Pages: |
e84340 |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion, Feng-Chun Yang |
Allele Type: |
Transgenic |
Attribute String: |
Epitope tag, Inserted expressed sequence |
|
•
•
•
•
•
|
Allele |
Name: |
vav 1 oncogene; targeted mutation 1.1, Teresa Palomero |
Allele Type: |
Targeted |
Attribute String: |
Conditional ready, Inserted expressed sequence |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, mutant strain, transgenic |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, mutant strain, transgenic |
|
•
•
•
•
•
|
Strain |
Attribute String: |
transgenic, coisogenic, mutant strain |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tg(Vav1-JAK2*V617F)AZjz/? |
Background: |
involves: C57BL/6 * DBA/2 |
Zygosity: |
ot |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Bcr/Bcr Tg(Vav1-cre)#Cgp/? |
Background: |
involves: C57BL/6 |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Bcr/Bcr<+> Tg(Vav1-cre)#Cgp/? |
Background: |
involves: C57BL/6 |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Otud5/Otud5 Tg(Vav1-cre)#Cgp/? |
Background: |
involves: C57BL/6 |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Srf/Srf Tg(Vav1-cre)#Cgp/? |
Background: |
involves: 129S6/SvEvTac * C57BL/6J |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Rpl22l1/Rpl22l1 Tg(Vav1-cre)#Cgp/? |
Background: |
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
45
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Liu S |
Year: |
2016 |
Journal: |
FEBS Lett |
Title: |
Structural basis for a novel interaction between TXNIP and Vav2. |
Volume: |
590 |
Issue: |
6 |
Pages: |
857-65 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ulc A |
Year: |
2017 |
Journal: |
Biol Chem |
Title: |
Involvement of the guanine nucleotide exchange factor Vav3 in central nervous system development and plasticity. |
Volume: |
398 |
Issue: |
5-6 |
Pages: |
663-675 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
This entry represents the SH2 domain of VAV2, which is a member of the VAV family. The SH2 domain of VAV2 has been shown to interact with PPxY motifs of TXNIP (thioredoxin-interacting protein) []. The VAV protein family members are multiple domain proteins, including Vav from flies and VAV1/2/3 from mammals. VAV1 predominates in hematopoietic cells, whereas VAV2 and VAV3 are more broadly expressed. They have a calponin homology (CH) domain, an acidic domain (AC), a Dbl homology (DH) domain, a pleckstrin homology (PH) domain, a cysteine-rich (CR) domain containing a zinc finger, and a complex region with SH2 and SH3 domains. Therefore they may participate in the activity of several pathways [, ]. They are signal transducer proteins that couple tyrosine kinase signals with the activation of the Rho/Rac GTPases, [, , ]. |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
This entry represents the SH2 domain of VAV3, which belongs to the VAV family. VAV3 is involved in the regulation of osteoclast function []and in central nervous system development and plasticity [].The VAV protein family members are multiple domain proteins, including Vav from flies and VAV1/2/3 from mammals. VAV1 predominates in hematopoietic cells, whereas VAV2 and VAV3 are more broadly expressed. They have a calponin homology (CH) domain, an acidic domain (AC), a Dbl homology (DH) domain, a pleckstrin homology (PH) domain, a cysteine-rich (CR) domain containing a zinc finger, and a complex region with SH2 and SH3 domains. Therefore they may participate in the activity of several pathways [, ]. They are signal transducer proteins that couple tyrosine kinase signals with the activation of the Rho/Rac GTPases, [, , ]. |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
The adaptor protein 3BP2/SH3BP2 is a cytoplasmic adaptor that contributes to the regulation of immune responses []. The protein-tyrosine kinase Syk phosphorylates 3BP2 which results in the activation of Rac1 through the interaction with the SH2 domain of Vav1 and induces the binding to the SH2 domain of the upstream protein-tyrosine kinase Lyn and enhances its kinase activity []. 3BP2 has a positive regulatory role in IgE-mediated mast cell activation []. In lymphocytes, engagement of T cell or B cell receptors triggers tyrosine phosphorylation of 3BP2 []. 3BP2 is required for the proliferation of B cells and B cell receptor signaling. Mutations in the 3BP2 gene are responsible for cherubism resulting in excessive bone resorption in the jaw [].This entry represents the SH2 domain of SH3BP2. |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
The adaptor protein 3BP2/SH3BP2 is a cytoplasmic adaptor that contributes to the regulation of immune responses []. The protein-tyrosine kinase Syk phosphorylates 3BP2 which results in the activation of Rac1 through the interaction with the SH2 domain of Vav1 and induces the binding to the SH2 domain of the upstream protein-tyrosine kinase Lyn and enhances its kinase activity []. 3BP2 has a positive regulatory role in IgE-mediated mast cell activation []. In lymphocytes, engagement of T cell or B cell receptors triggers tyrosine phosphorylation of 3BP2 []. 3BP2 is required for the proliferation of B cells and B cell receptor signaling. Mutations in the 3BP2 gene are responsible for cherubism resulting in excessive bone resorption in the jaw []. |
|
•
•
•
•
•
|
Publication |
First Author: |
Roncagalli R |
Year: |
2014 |
Journal: |
Nat Immunol |
Title: |
Quantitative proteomics analysis of signalosome dynamics in primary T cells identifies the surface receptor CD6 as a Lat adaptor-independent TCR signaling hub. |
Volume: |
15 |
Issue: |
4 |
Pages: |
384-392 |
|
•
•
•
•
•
|
Publication |
First Author: |
Dorn T |
Year: |
2007 |
Journal: |
Blood |
Title: |
RhoH is important for positive thymocyte selection and T-cell receptor signaling. |
Volume: |
109 |
Issue: |
6 |
Pages: |
2346-55 |
|
•
•
•
•
•
|
Publication |
First Author: |
Brantley-Sieders DM |
Year: |
2009 |
Journal: |
Mol Cancer Res |
Title: |
Host deficiency in Vav2/3 guanine nucleotide exchange factors impairs tumor growth, survival, and angiogenesis in vivo. |
Volume: |
7 |
Issue: |
5 |
Pages: |
615-23 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jia W |
Year: |
2021 |
Journal: |
Nat Commun |
Title: |
Indispensable role of Galectin-3 in promoting quiescence of hematopoietic stem cells. |
Volume: |
12 |
Issue: |
1 |
Pages: |
2118 |
|
•
•
•
•
•
|
Publication |
First Author: |
Guy CS |
Year: |
2013 |
Journal: |
Nat Immunol |
Title: |
Distinct TCR signaling pathways drive proliferation and cytokine production in T cells. |
Volume: |
14 |
Issue: |
3 |
Pages: |
262-70 |
|
•
•
•
•
•
|
Publication |
First Author: |
Proto JD |
Year: |
2018 |
Journal: |
Immunity |
Title: |
Regulatory T Cells Promote Macrophage Efferocytosis during Inflammation Resolution. |
Volume: |
49 |
Issue: |
4 |
Pages: |
666-677.e6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hoefig KP |
Year: |
2021 |
Journal: |
Nat Commun |
Title: |
Defining the RBPome of primary T helper cells to elucidate higher-order Roquin-mediated mRNA regulation. |
Volume: |
12 |
Issue: |
1 |
Pages: |
5208 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gomez TS |
Year: |
2006 |
Journal: |
Immunity |
Title: |
HS1 functions as an essential actin-regulatory adaptor protein at the immune synapse. |
Volume: |
24 |
Issue: |
6 |
Pages: |
741-52 |
|
•
•
•
•
•
|
Publication |
First Author: |
Titelbaum M |
Year: |
2021 |
Journal: |
iScience |
Title: |
Ezh2 harnesses the intranuclear actin cytoskeleton to remodel chromatin in differentiating Th cells. |
Volume: |
24 |
Issue: |
10 |
Pages: |
103093 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hardin AO |
Year: |
2006 |
Journal: |
Biochem Biophys Res Commun |
Title: |
SHP-1 inhibits LPS-mediated TNF and iNOS production in murine macrophages. |
Volume: |
342 |
Issue: |
2 |
Pages: |
547-55 |
|
•
•
•
•
•
|
Publication |
First Author: |
Laufer JM |
Year: |
2019 |
Journal: |
Cell Rep |
Title: |
Chemokine Receptor CCR7 Triggers an Endomembrane Signaling Complex for Spatial Rac Activation. |
Volume: |
29 |
Issue: |
4 |
Pages: |
995-1009.e6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Park CS |
Year: |
2012 |
Journal: |
J Leukoc Biol |
Title: |
Kruppel-like factor 4 (KLF4) promotes the survival of natural killer cells and maintains the number of conventional dendritic cells in the spleen. |
Volume: |
91 |
Issue: |
5 |
Pages: |
739-50 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hutter K |
Year: |
2021 |
Journal: |
FEBS J |
Title: |
Differential roles of miR-15a/16-1 and miR-497/195 clusters in immune cell development and homeostasis. |
Volume: |
288 |
Issue: |
5 |
Pages: |
1533-1545 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tuzlak S |
Year: |
2018 |
Journal: |
FEBS J |
Title: |
Differential effects of Vav-promoter-driven overexpression of BCLX and BFL1 on lymphocyte survival and B cell lymphomagenesis. |
Volume: |
285 |
Issue: |
8 |
Pages: |
1403-1418 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chow A |
Year: |
2013 |
Journal: |
Nat Med |
Title: |
CD169⁺ macrophages provide a niche promoting erythropoiesis under homeostasis and stress. |
Volume: |
19 |
Issue: |
4 |
Pages: |
429-36 |
|
•
•
•
•
•
|
Publication |
First Author: |
Herold MJ |
Year: |
2014 |
Journal: |
Cell Death Dis |
Title: |
Impact of conditional deletion of the pro-apoptotic BCL-2 family member BIM in mice. |
Volume: |
5 |
|
Pages: |
e1446 |
|
•
•
•
•
•
|
Strain |
Attribute String: |
transgenic, mutant strain, congenic |
|
•
•
•
•
•
|
Publication |
First Author: |
Grahn THM |
Year: |
2020 |
Journal: |
Leukemia |
Title: |
S100A6 is a critical regulator of hematopoietic stem cells. |
Volume: |
34 |
Issue: |
12 |
Pages: |
3323-3337 |
|
•
•
•
•
•
|
Publication |
First Author: |
Luo L |
Year: |
2020 |
Journal: |
J Immunol |
Title: |
Kras-Deficient T Cells Attenuate Graft-versus-Host Disease but Retain Graft-versus-Leukemia Activity. |
Volume: |
205 |
Issue: |
12 |
Pages: |
3480-3490 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lamrani L |
Year: |
2014 |
Journal: |
Blood |
Title: |
Hemostatic disorders in a JAK2V617F-driven mouse model of myeloproliferative neoplasm. |
Volume: |
124 |
Issue: |
7 |
Pages: |
1136-45 |
|
•
•
•
•
•
|
Publication |
First Author: |
Liu MH |
Year: |
2021 |
Journal: |
Leukemia |
Title: |
FAM122A is required for hematopoietic stem cell function. |
Volume: |
35 |
Issue: |
7 |
Pages: |
2130-2134 |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tg(Vav1-Asxl1*Y588X)#Fcy/? |
Background: |
C57BL/6-Tg(Vav1-Asxl1*Y588X)#Fcy |
Zygosity: |
ot |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nbn/Nbn Tg(VAV1-cre)1Graf/? |
Background: |
involves: 129P2/OlaHsd |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tg(VAV1-cre)1Graf/? |
Background: |
involves: 129 * C57BL/6 |
Zygosity: |
ot |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tg(VAV1-cre)1Graf/? |
Background: |
Not Specified |
Zygosity: |
ot |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tg(VAV1-cre)1Graf/? |
Background: |
involves: 129P2/OlaHsd |
Zygosity: |
ot |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tg(VAV1-cre)1Graf/? |
Background: |
involves: C57BL/6 |
Zygosity: |
ot |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|